Likewise, it is possible that decreased podocyte APOL1 expression under disease conditions leads to decreased cholesterol efflux from podocytes and cellular cholesterol accumulation, thus contributing to the pathogenesis of glomerular diseases such as FSGS and HIVAN. This evidence concerns the gene APOL1 and focal segmental glomerulosclerosis.